All
Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel
Paller discusses the promising phase 3 trial SELVA trial results for Qtorin 3.9% rapamycin gel, an investigative treatment for microcystic lymphatic malformations.
JAK Inhibitors as Flexible, Fast-Acting Option for Refractory AD
Raj Chovatiya, MD, PhD, MSCI, provides insights on the clinical advantages of JAK inhibitors for atopic dermatitis.
Understanding Chronic Hand Eczema: Cellular Mechanisms and Therapeutic Implications
Omar Noor, MD, FAAD, explores the complex immune and cellular mechanisms behind CHE and highlights its significant physical and emotional toll on patients.
New Insights into Biologic Therapies for BP
Complete remission was achieved in over 87% of dupilumab users and 64% of omalizumab users.
What Dermatologists Need to Know About the Future of Regenerative Aesthetics
While products like growth factor skincare already have demonstrated benefits, this is only the beginning, according to Prithwiraj Maitra, PhD.
Dual-Energy Approach Boosts Skin Hydration
A Comprehensive Approach to Managing Chronic Spontaneous Urticaria and Enhancing Patient Care: A Q&A With Priya Bansal, MD
Journal Digest: April 23
This review of the latest dermatologic studies includes insights into epidermolysis bullosa for primary care providers, patient-reported impact of atopic dermatitis on pediatric and adolescent patients, and more.
Daily Derm Times: April 22, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes
Researchers conduct a review to understand the efficacy and safety of topical minocycline for the treatment of moderate to severe papulopustular rosacea.
Using Real-World AD Cases to Pick the Right Therapy for Each Patient
In a recent Dermatology Times Case-Based Peer Perspectives custom video series, Naiem Issa, MD, PhD, reviewed 3 complex patient cases of atopic dermatitis.
Isotretinoin Often Continued Despite Mood Concerns
Despite early psychological symptoms, over half of patients in the study completed their full treatment course.
Redefining Anti-Aging with Regenerative Aesthetics and Growth Factor Skincare
Prithwiraj Maitra, PhD, Vice President of Global Skincare R&D at Allergan Aesthetics, gave his thoughts on regenerative aesthetics and other recent skincare advancements.
Teledermatology Preferences Among Patients with Psoriasis
Continuity with a known physician and rapid response times significantly increased patient willingness to use teledermatology.
Palvella Secures New US Patent for Qtorin Rapamycin in Microcystic Lymphatic Malformations
Palvella has secured its 5th US patent for Qtorin rapamycin, extending intellectual property coverage to 2038 and advancing treatment for microcystic lymphatic malformations.
Survey Unveils Impact of Chronic Hand Eczema on Patients’ Lives and Treatment Landscape
A survey by LEO Pharma indicates widespread misunderstandings about chronic hand eczema, revealing significant emotional and occupational challenges for patients.
Daily Derm Times: April 21, 2025
Understanding the Role of the Microbiome in Rosacea
Over the past few years, research on the microbiome and dysbiosis has gained interest in the potential exacerbation of several skin diseases, including rosacea.
Newly Developed REACH Score Identifies Burden for Employed Patients with Chronic Wounds
Nearly half of the surveyed patients identified a negative impact of their wounds on daily life, particularly at work.
Larry Eichenfield, MD: Safety, Convenience, and Future Role of Icotrokinra in Treating Adolescent Psoriasis
Eichenfield discusses safety, lab monitoring, and treatment positioning of icotrokinra in adolescents with moderate to severe plaque psoriasis.
Andrew Baker, MBA, MPAS, PA-C, Shares Vision for SDPA Leadership
Strengthening interdisciplinary relationships remains a central part of Baker’s focus.
The Future of AI-Powered Skincare
Anastasia Georgievskaya reflects on the success of SkinGPT and reveals upcoming plans and potential advancements in artificial intelligence and dermatology.
AD Misconceptions with Peter Lio, MD
While dietary changes can help slightly, they’re not a cure-all for most patients with AD.
Keratin Hair Treatments and Formaldehyde Exposure
Keratin hair treatments straighten, smooth, and add shine—though formaldehyde risks raise safety concerns for dermatologists and salon professionals.
Top 5 Articles of the Week: April 13-18
Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.
Dermatology Times' Sunday Crossword: April 20, 2025
Test your knowledge of key words and terms associated with dermatology news from the previous week.
The Weekly Roundup: April 14-18
In case you missed it, this week we had news about HyBryte's treatment success in CTCL patients, the impact of the COVID-19 pandemic on BCC surgeries, the FDA approval of dupilumab for H1 antihistamine-refractory CSU, and more.
The Rx Recap: April 13-19
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
Daily Derm Times: April 18, 2025
Treating Rosacea and Other Concerns with Generative Skin’s Ingredient Library
As a patient with rosacea herself, Anastasia Georgievskaya highlights the innovation of Generative Skin in patient education.